Filter Results
:
(599)
Show Results For
-
All HBS Web
(1,023)
- People (4)
- News (249)
- Research (599)
- Events (7)
- Multimedia (24)
- Faculty Publications (389)
Show Results For
-
All HBS Web
(1,023)
- People (4)
- News (249)
- Research (599)
- Events (7)
- Multimedia (24)
- Faculty Publications (389)
Sort by
- 25 Feb 2014
- First Look
First Look: February 25
is based in Massachusetts and lists in London on AIM. Products are genetically modified fast-growing salmon for fish farmers and disease-prevention drugs and diagnostic kits for farmed shrimp. Purchase this case:...
View Details
Keywords:
Sean Silverthorne
- 23 Aug 2016
- First Look
August 23, 2016
particular, we examine how individuals’ prior experiences and the experiences of those around them alter their belief perseverance in operational decisions after the revelation of negative news. We draw on an exogenous announcement of negative news by the Food and...
View Details
Keywords:
Sean Silverthorne
- 19 Oct 2015
- Research & Ideas
Business Research that Makes for Smarter Public Policy
Ginger Jin, of the Maryland Center for Economics and Policy, is just one example. They invited regulatory officials from several leading federal agencies, including the Department of Agriculture (USDA), Environmental Protection Agency (EPA), Food and View Details
Keywords:
by Michael Blanding
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in...
View Details
Keywords:
Martha Lagace
- 01 Jul 2008
- First Look
First Look: July 1, 2008
establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate? Purchase...
View Details
Keywords:
Martha Lagace
- 24 Jun 2014
- First Look
First Look: June 24
malaria-"at no profit"-for public health systems. What had begun as an exemplary act of corporate responsibility had succeeded beyond any expectations. In 2012, for the second year in a row, Novartis had manufactured and distributed over 100 million units of...
View Details
Keywords:
Sean Silverthorne
- 30 Jun 2020
- Book
Capitalism Is More at Risk Than Ever
profitability. In Chapter 6 we describe the work of drug company Cipla in India and telephone company China Mobile working in rural western China to bring affordable drugs, and smart telephone connections, respectively, to hundreds of...
View Details
Keywords:
by Martha Lagace
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
at the US Food and Drug Administration and the Centers for Medicare and Medicaid Services. The pandemic has made it clear that this must change. Richard Hamermesh (@RHamermesh) is a Baker Foundation Professor of Management Practice and...
View Details
Keywords:
by Danielle Kost
- 12 May 2009
- First Look
First Look: May 12, 2009
their practices. Sermo earns revenue by charging clients who would value early information regarding the effectiveness of new drugs and medical devices-investment managers, pharmaceutical companies, and regulatory authorities. Clients...
View Details
Keywords:
Martha Lagace
- 10 Sep 2007
- Research & Ideas
High Note: Managing the Medici String Quartet
Robertson working for you as your key software developer, drug researcher, or designer, he would be a handful, to say the least. There are key people in these kinds of businesses, and they are what they are. One of the managing partners...
View Details
- 13 Sep 2011
- First Look
First Look: September 13
come primarily from the non-drug treatment (87.4% and 70.2% respectively), whereas gains from detailing come at the expense of competing drugs (84%). By contrast, the random coefficient logit model predicts that gains from DTCA, M&E,...
View Details
Keywords:
Sean Silverthorne
- 18 Sep 2007
- First Look
First Look: September 18, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=907025 NatuRi Corporation Harvard Business School Case 807-027 NatuRi Corporation was a start up, founded in 2005, aiming to manufacture a cholesterol-lowering drug made from...
View Details
Keywords:
Martha Lagace
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
Ph.D. in biology and a former biology professor at Harvard, has also had a 25-year career in drug development and biotech companies, leading both R&D and business functions. She teaches the MBA elective Inventing Breakthroughs and...
View Details
- 30 Jun 2003
- Research & Ideas
Computer Security is For Managers, Too
each warrants. A bank, for instance, might assign the greatest amount of protection to the database that stores its customers' financial information. For a pharmaceutical company, it might be the research servers that hold data on promising View Details
- 14 Dec 2010
- First Look
First Look: Dec. 14
511-075 By 2009, Hikma Pharmaceuticals operated 13 manufacturing plants in 8 countries of which 5 were approved by the U.S. Food and Drug Administration. Hikma tracked its sales revenues over the period to show from where the largest...
View Details
Keywords:
Sean Silverthorne
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
mother gave me a copy of The Jungle by Upton Sinclair. I was very struck by that book. I find the writing, in retrospect, really wretched, but the kind of passion that said, "Here is an awful system," was pivotal in getting food and View Details
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
with revenue expectations of $1 billion in 2015. At the time of the acquisition, AbbVie received more than 60% of its sales from the drug Humira, a biologic agent used to treat several autoimmune diseases and malignancies. However, Humira...
View Details
Keywords:
Sean Silverthorne
- 12 Feb 2008
- First Look
First Look: February 12, 2007
stake of 9.5% in Ligand Pharmaceuticals, Inc., a specialty pharmaceutical company. Third Point believed that Ligand had a strong drug portfolio and pipeline but that it was highly undervalued due to poor management. After gaining board...
View Details
Keywords:
Martha Lagace
- 19 Jun 2012
- First Look
First Look: June 19
312-002 McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010...
View Details
Keywords:
Sean Silverthorne
- 24 Jul 2007
- First Look
First Look: July 24, 2007
the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. Purchase this case:...
View Details
Keywords:
Martha Lagace